{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:47:00Z","timestamp":1782895620693,"version":"3.54.5"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Gout, an inflammatory form of arthritis triggered by monosodium urate (MSU) crystal deposition, poses a substantial global health burden with increasing prevalence and younger onset, particularly in China. In traditional Chinese medicine (TCM), dampness-heat accumulation is a predominant pattern associated with gout.\n                      <jats:italic>Smilax glabra<\/jats:italic>\n                      (\n                      <jats:italic>Tufuling<\/jats:italic>\n                      ), a medicinal and edible herb with a history of use for detoxification and elimination of dampness, is also known to promote joint mobility. It is widely used for these purposes. This study aimed to systematically evaluate the clinical efficacy and safety of\n                      <jats:italic>Tufuling<\/jats:italic>\n                      -containing TCM formulae\u2014typically used in combination with other Chinese herbs and\/or Western medicine\u2014for gout patients with dampness-heat accumulation, and to generate testable mechanistic hypotheses using network pharmacology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A systematic review (SR) and meta-analysis were conducted by searching PubMed, Embase, CNKI, and other databases from inception to June 2025, including randomized controlled trials (RCTs) of formulae containing\n                      <jats:italic>Tufuling<\/jats:italic>\n                      interventions for gout. Network pharmacology was utilized to identify active compounds, target genes, and key pathways involved in gout treatment, followed by molecular docking to generate mechanistic hypotheses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 56 RCTs involving 4,605 participants were included in this analysis. A meta-analysis revealed that\n                      <jats:italic>Tufuling<\/jats:italic>\n                      -containing formulae, particularly when combined with Western medicine (WM) or administered as comprehensive TCM therapy, were associated with reductions in, visual analog scale (VAS) scores (pain), serum uric acid (UA) levels, C-reactive protein (CRP) levels, and the erythrocyte sedimentation rate (ESR) compared with WM monotherapy. A lower reported incidence of gastrointestinal adverse events was observed (73 vs. 161 cases); however, adverse event reporting was incomplete, treatment durations were short, and the follow-up data were limited. Meta-analysis suggested that simpler interventions may be associated with fewer adverse events. Network pharmacology predicted 11, 3, and 14 active compounds for\n                      <jats:italic>Tufuling<\/jats:italic>\n                      ,\n                      <jats:italic>Huangbo<\/jats:italic>\n                      , and\n                      <jats:italic>Bixie<\/jats:italic>\n                      , respectively. Target mapping predicted 49 targets for\n                      <jats:italic>Tufuling<\/jats:italic>\n                      , 81 for the\n                      <jats:italic>Tufuling<\/jats:italic>\n                      \u2013\n                      <jats:italic>Huangbo<\/jats:italic>\n                      pair, and 7 for\n                      <jats:italic>Bixie<\/jats:italic>\n                      \u2014all nested within the\n                      <jats:italic>Tufuling<\/jats:italic>\n                      target set. The\n                      <jats:italic>Tufuling<\/jats:italic>\n                      PPI network (48 nodes, 348 edges) identified four core targets: PTGS2, IL1B, PPARG, and TP53. The\n                      <jats:italic>Tufuling<\/jats:italic>\n                      \u2013\n                      <jats:italic>Huangbo<\/jats:italic>\n                      PPI network (76 nodes, 1,054 edges) yielded seven core targets; four overlapped with\n                      <jats:italic>Tufuling<\/jats:italic>\n                      , while CCL2, BCL2, and CXCL8 were\n                      <jats:italic>Huangbo<\/jats:italic>\n                      -specific. KEGG analysis of 48\n                      <jats:italic>Tufuling<\/jats:italic>\n                      targets identified 228 pathways, with key enrichment in metabolism, lipid and atherosclerosis, PI3K\u2013Akt, TNF, and IL-17 signaling. The 76\n                      <jats:italic>Tufuling<\/jats:italic>\n                      \u2013\n                      <jats:italic>Huangbo<\/jats:italic>\n                      targets revealed 233 pathways, showing enhanced enrichment in PI3K\u2013Akt, NOD-like receptor, MAPK, TNF, and IL-17 signaling relative to\n                      <jats:italic>Tufuling<\/jats:italic>\n                      alone. Molecular docking predicted For the\n                      <jats:italic>Tufuling<\/jats:italic>\n                      , diosgenin would bound PTGS2 most strongly (\u221211.6 kcal\/mol), followed by TP53 (\u22129.8kcal\/mol) and IL1B (\u22128.0kcal\/mol); beta-sitosterol would bound PPARG (\u22129.2kcal\/mol). For the\n                      <jats:italic>Tufuling<\/jats:italic>\n                      \u2013\n                      <jats:italic>Huangbo<\/jats:italic>\n                      pair, beta-sitosterol additionally would bound BCL2 (\u22127.9kcal\/mol). For\n                      <jats:italic>Bixie<\/jats:italic>\n                      , diosgenin would bound PLA2G4A (\u221210.3kcal\/mol) and PTGS2 (\u22129.9kcal\/mol), while EINECS 213-897\u20130 would bound NR3C2 (\u22128.9kcal\/mol).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Tufuling<\/jats:italic>\n                      -containing formulae may be associated with symptomatic improvements in acute gout with dampness-heat accumulation, including analgesic, anti-inflammatory, and uric acid\u2013lowering effects, although the certainty of evidence ranges from low to moderate. The safety profile appears promising but remains inadequately characterized due to incomplete reporting and short follow-up. The efficacy of this treatment may be mediated by multiple compounds and multi-target modulation of inflammatory and metabolic pathways.\n                      <jats:italic>Tufuling<\/jats:italic>\n                      -based interventions have been identified as potentially valuable adjunctive therapies for the treatment of gout. However, further rigorous RCTs and experimental studies are needed to validate its long-term efficacy and mechanism of action.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , identifier CRD420251060498.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1863098","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:09:56Z","timestamp":1782893396000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional therapeutic advantages of Smilax glabra (Tufuling)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction"],"prefix":"10.3389","volume":"17","author":[{"given":"Qiaoyun","family":"Liu","sequence":"first","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]},{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Lin","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]},{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Tang","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]},{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjie","family":"Fan","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]},{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Sun","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, China"]},{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215933","article-title":"Gout, hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout","volume":"78","author":"Bursill","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23607","article-title":"Gout, hyperuricemia, and crystal-associated disease network consensus statement regarding labels and definitions for disease elements in gout","volume":"71","author":"Bursill","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.41404","article-title":"Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990\u20132017: a systematic analysis of the global burden of disease study 2017","volume":"72","author":"Safiri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201392","article-title":"Gout diagnosis and treatment specification","volume":"62","author":"Xu","year":"2023","journal-title":"Chin J Intern Med"},{"key":"B5","article-title":"Guidelines for diagnosis and treatment of gout and hyperuricemia with integrated disease and syndrome","volume":"62","author":"Jiang","year":"2021","journal-title":"J Tradit Chin Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.12114\/j.issn.1007-9572.2024.0614","article-title":"Meta-analysis of the prevalence of hyperuricemia in children and adolescents in China","volume":"28","author":"Xiang","year":"2025","journal-title":"Chin Gen Pract"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.70378","article-title":"Clinical practice consensus statement 2025: management of hyperuricemia and gout in adolescents","volume":"28","author":"Li","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"B8","article-title":"Dietary guidelines for adult hyperuricemia and gout (2024 edition)","year":"2024"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-7202.2021.02.001","article-title":"Guidelines for diagnosis and treatment of hyperuricemia and gout with integrated disease and syndrome (2021-01-20)","volume":"16","author":"Ni","year":"2021","journal-title":"World Chin Med"},{"key":"B10","volume-title":"Notice on further regulating the management of health food ingredients","year":"2002"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7873426","article-title":"Efficacy and safety of qinpi tongfeng formula in the treatment of acute gouty arthritis: A double-blind, double-dummy, multicenter, randomized controlled trial","volume":"2022","author":"Fan","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1426.2016.12.002","article-title":"2016 Chinese gout diagnosis and treatment guidelines","volume":"55","year":"2016","journal-title":"Chin J Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/cma.j.issn.1000-6699.2020.01.001","article-title":"Chinese guidelines for diagnosis and treatment of hyperuricemia and gout (2019)","volume":"36","year":"2020","journal-title":"Chin J Endocrinol Metab"},{"key":"B14","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","year":"2011"},{"key":"B15","article-title":"Clinical efficacy of modified Simiao Pill combined with loxoprofen sodium in treating acute gouty arthritis of damp-heat accumulation type","volume":"15","author":"Cao","year":"2020","journal-title":"China J Pharm Econ"},{"key":"B16","article-title":"Clinical observation on Tongfeng Decoction combined with celecoxib capsules for acute gouty arthritis of damp-heat accumulation type","volume":"50","author":"Wan","year":"2018","journal-title":"New Chin Med"},{"key":"B17","article-title":"Clinical study on Qingre Qushi Decoction combined with Baiyao Ointment for acute gouty arthritis. (Master's thesis)","author":"Du","year":"2018"},{"key":"B18","article-title":"Clinical study on modified Simiao Decoction for gouty arthritis of damp-heat accumulation type. (Master's thesis)","author":"Huang","year":"2013"},{"key":"B19","article-title":"Effects of Xiahua Zhuoyu Decoction on serum inflammatory factors, oxidative stress and related matrix metalloproteinases in patients with acute gouty arthritis","volume":"32","author":"Jiang","year":"2023","journal-title":"J Emerg Tradit Chin Med"},{"key":"B20","article-title":"Clinical observation on Qinghua Xiaotong Decoction for acute gouty arthritis with damp-heat accumulation and phlegm-stasis type. (Master's thesis)","author":"Li","year":"2022"},{"key":"B21","article-title":"Clinical observation on Tongbi Tai Decoction combined with celecoxib capsules for 60 cases of acute gouty arthritis","volume":"12","author":"Li","year":"2023","journal-title":"Rheumatism Arthritis"},{"key":"B22","article-title":"Effect of Qingli Huoxue Jiedu Decoction combined with Zhongtongxiao external application on joint function in elderly acute gouty arthritis","volume":"39","author":"Li","year":"2021","journal-title":"Sichuan J Tradit Chin Med"},{"key":"B23","article-title":"Effect of Qingre Lishi therapy on acute gouty arthritis","volume":"17","author":"Li","year":"2020","journal-title":"China Med Herald"},{"key":"B24","first-page":"3","article-title":"Clinical observation on Simiao Powder plus Tufuling for gouty arthritis","volume":"52","author":"Lin","year":"2023","journal-title":"Heilongjiang J Tradit Chin Med"},{"key":"B25","article-title":"Efficacy observation of Qingre Qushi Zhitong Decoction combined with meridian segment thread-embedding therapy for acute gouty arthritis","volume":"31","author":"Liu","year":"2022","journal-title":"J Emerg Tradit Chin Med"},{"key":"B26","article-title":"Clinical study on Tongfeng Decoction combined with western medicine for acute gouty arthritis of damp-heat and stasis type","author":"Liu","year":"2016","journal-title":"(Master's thesis)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.13935\/j.cnki.sjzx.210826","article-title":"Effect of intradermal needle combined with Simiao Powder and Simiao Yong\u2019an Decoction on acute gouty arthritis with damp-heat type","volume":"16","author":"Liu","year":"2021","journal-title":"World J Integr Tradit West Med"},{"key":"B28","article-title":"Clinical observation on Xiaotong Yin combined with etoricoxib for acute gouty arthritis (damp-heat accumulation type)","author":"Liu","year":"2019"},{"key":"B29","article-title":"Clinical observation on modified Simiao Decoction combined with external application of Chinese medicine for acute gouty arthritis of damp-heat accumulation type","author":"Liu","year":"2008","journal-title":"(Master's thesis)"},{"key":"B30","article-title":"Effect of Yinshan Dan Decoction on serum IgA, IgG, IgM levels and efficacy in acute gouty arthritis","author":"Lyu","year":"2022","journal-title":"(Master's thesis)"},{"key":"B31","article-title":"Clinical observation on Shentongling No. 1 for acute gouty arthritis of damp-heat accumulation type","volume":"42","author":"Ma","year":"2020","journal-title":"Hebei J Tradit Chin Med"},{"key":"B32","article-title":"Clinical efficacy observation of Qingre Lishi Tongluo Decoction for acute gouty arthritis of damp-heat obstruction syndrome","author":"Nan","year":"2020","journal-title":"(Master's thesis)"},{"key":"B33","article-title":"Treatment of 45 cases of acute gouty arthritis of damp-heat obstruction type with Tongfeng Xiaobi Decoction","volume":"25","author":"Nie","year":"2012","journal-title":"J Tradit Chin Med Res"},{"key":"B34","article-title":"Clinical observation on modified Sanmiao Powder in treating acute gouty arthritis","volume":"30","author":"Yuan","year":"2014","journal-title":"Shanxi J Tradit Chin Med"},{"key":"B35","article-title":"Clinical observation on Qingre Lishi Zhuyu Decoction in treating gouty arthritis","volume":"22","author":"Qi","year":"2016","journal-title":"Chin J Exp Tradit Med Form"},{"key":"B36","article-title":"Clinical observation and mechanism of Qingre Lishi Zhuyu Decoction combined with health education in treating gouty arthritis","volume":"32","author":"Qi","year":"2017","journal-title":"Guangming J Chin Med"},{"key":"B37","article-title":"Efficacy observation of integrated traditional Chinese and western medicine for acute gouty arthritis","volume":"28","author":"Qin","year":"2019","journal-title":"J Emerg Tradit Chin Med"},{"key":"B38","article-title":"Clinical observation on modified Simiao Powder for gouty arthritis of damp-heat accumulation type","volume":"36","author":"Rong","year":"2021","journal-title":"Guangming J Chin Med"},{"key":"B39","article-title":"Clinical observation on Juanbi Lijie Qing Decoction combined with Xiaoyan Powder for acute gouty arthritis of damp-heat accumulation type","volume":"39","author":"Shen","year":"2023","journal-title":"Shanxi J Tradit Chin Med"},{"key":"B40","article-title":"Effect of Qingli Huoxue Jiedu Decoction adjuvant therapy for acute gouty arthritis","volume":"40","author":"Song","year":"2021","journal-title":"Inner Mongolia J Tradit Chin Med"},{"key":"B41","article-title":"Efficacy of Qufeng Tongluo Lishi Chinese medicine for gouty arthritis of damp-heat obstruction syndrome and its effect on MMP-3 and COX-2","volume":"26","author":"Song","year":"2017","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"B42","article-title":"Clinical observation on Tongfeng Decoction for gout of damp-heat and stasis type","volume":"23","author":"Sun","year":"2017","journal-title":"Chin J Exp Tradit Med Form"},{"key":"B43","article-title":"Clinical study on Bi Ning Decoction in treating acute gouty arthritis","volume":"44","author":"Tong","year":"2016","journal-title":"J Tradit Chin Med"},{"key":"B44","first-page":"598","article-title":"Clinical observation on acupuncture combined with Chinese medicine for gouty arthritis","volume":"39","author":"Wang","year":"2020","journal-title":"Shanghai J Acupunct Moxibustion"},{"key":"B45","article-title":"Clinical observation on Qingli Huoxue Jiedu Decoction for gouty arthritis of damp-heat accumulation type","volume":"22","author":"Wang","year":"2016","journal-title":"Chin J Exp Tradit Med Form"},{"key":"B46","article-title":"Clinical observation of Tongfeng Decoction in treating acute gouty arthritis (damp-heat accumulation syndrome)","author":"Wang","year":"2011","journal-title":"(Master's thesis)"},{"key":"B47","article-title":"Clinical observation on Wei Ling Qushi Decoction for acute gouty arthritis of damp-heat obstruction type","author":"Wang","year":"2022","journal-title":"(Master's thesis)"},{"key":"B48","article-title":"Clinical observation on modified Mufangji Decoction for acute gouty arthritis of damp-heat accumulation syndrome","volume":"34","author":"Wang","year":"2020","journal-title":"J Pract Tradit Chin Intern Med"},{"key":"B49","article-title":"Clinical study on modified Zexie Drink for acute gouty arthritis of damp-heat and stasis type","author":"Wei","year":"2020","journal-title":"(Master's thesis)"},{"key":"B50","first-page":"73","article-title":"Clinical efficacy of Simiao Tongfeng Granules on chronic gout acute attack and its effect on IL-1\u03b2 and NALP3","volume":"29","author":"Wu","year":"2020","journal-title":"J Emerg Tradit Chin Med"},{"key":"B51","first-page":"16","article-title":"Efficacy of Qingre Lishi Decoction combined with loxoprofen sodium tablets on acute gouty arthritis and its effect on cytokines","volume":"28","author":"Xi","year":"2021","journal-title":"Mod Clin Tradit Chin Med"},{"key":"B52","article-title":"Clinical study on Qingre Qushi Tongluo Decoction combined with conventional western medicine for acute gouty arthritis of damp-heat accumulation type","volume":"45","author":"Xia","year":"2023","journal-title":"Hebei J Tradit Chin Med"},{"key":"B53","article-title":"Clinical observation on electroacupuncture combined with external application of Chinese medicine for acute gouty arthritis","volume":"9","author":"Xiao","year":"2017","journal-title":"Clin J Chin Med"},{"key":"B54","article-title":"Qingre Tongbi Decoction combined with Chinese herbal fumigation for 30 cases of acute gouty arthritis","volume":"32","author":"Xie","year":"2013","journal-title":"Shandong J Tradit Chin Med"},{"key":"B55","first-page":"3","article-title":"Clinical study on Jianpi Bushen Xiezhuo therapy for gouty arthritis","volume":"15","author":"Xie","year":"2017","journal-title":"Guid Chin Med"},{"key":"B56","first-page":"69","article-title":"Clinical study on Bixie Qufeng Yin combined with Zhongtongxiao Ointment for acute gouty arthritis","volume":"27","author":"Xing","year":"2018","journal-title":"J Emerg Tradit Chin Med"},{"key":"B57","article-title":"Clinical study on Chushi Jiedu Decoction combined with Qianghuo Shengshi Decoction for acute gouty arthritis (damp-heat accumulation syndrome)","volume":"30","author":"Xiong","year":"2021","journal-title":"J Emerg Tradit Chin Med"},{"key":"B58","article-title":"Clinical efficacy of Qingre Xiezhuo Huayu Decoction for acute gouty arthritis","volume":"29","author":"Xu","year":"2019","journal-title":"Zhejiang J Integr Tradit Chin West Med"},{"key":"B59","article-title":"Clinical observation on Lingze Tongfeng Decoction for acute gouty arthritis","volume":"12","author":"Xu","year":"2020","journal-title":"Clin J Chin Med"},{"key":"B60","article-title":"Clinical study on Tongfeng Tongluo Agent for acute gouty arthritis of damp-heat accumulation type","author":"Xu","year":"2020","journal-title":"(Master's thesis)"},{"key":"B61","article-title":"Clinical study on modified Simiao Decoction for acute gouty arthritis","volume":"31","author":"Yang","year":"2019","journal-title":"Mod Pract Med"},{"key":"B62","article-title":"Clinical study on Qingli Huoxue Jiedu Granules for gout of damp-heat accumulation syndrome","author":"Yang","year":"2014","journal-title":"(Master's thesis)"},{"key":"B63","first-page":"4","article-title":"Effect of modified Simiao Powder on NLRP3 inflammatory signaling pathway in acute gouty arthritis","volume":"31","author":"Yang","year":"2021","journal-title":"Shenzhen J Integr Tradit Chin West Med"},{"key":"B64","first-page":"9","article-title":"Effect of Qingli Huoxue Jiedu Decoction on patients with gout of damp-heat accumulation type","volume":"20","author":"Yu","year":"2022","journal-title":"Chin J Med Res"},{"key":"B65","article-title":"Effect analysis of Chinese medicine Tongfeng Qingjie Decoction combined with Zhitong Xiaoyan Ointment and Jinhuang Powder external application for acute gouty arthritis","volume":"35","author":"Zeng","year":"2021","journal-title":"J Pract Tradit Chin Intern Med"},{"key":"B66","article-title":"Clinical observation on Tongfeng Tai Granules combined with Shuangbai Powder external application for acute gouty arthritis of damp-heat internal accumulation type","volume":"35","author":"Zhang","year":"2018","journal-title":"J Gansu Univ Chin Med"},{"key":"B67","article-title":"Clinical observation on Qingre Xiaobi Decoction combined with external application of Chinese medicine for acute gouty arthritis of damp-heat accumulation syndrome","author":"Zhang","year":"2021","journal-title":"(Master's thesis)"},{"key":"B68","article-title":"Clinical observation on Chinese medicine Tongfeng Decoction for acute gouty arthritis of damp-heat accumulation type","volume":"40","author":"Zhou","year":"2023","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"B69","article-title":"Clinical study on modified Baihu Guizhi Decoction for gouty arthritis of damp\u2011heat accumulation type","author":"Zou","year":"2021"},{"key":"B70","article-title":"Clinical study on modified Baihu Guizhi Decoction for gouty arthritis of damp-heat accumulation type","author":"Zou","year":"2021","journal-title":"(Master's thesis)"},{"key":"B71","article-title":"Clinical study on Tongfengshire Decoction combined with Shangke Huangshui for acute gout","author":"Ouyang","year":"2020","journal-title":"(Master's thesis)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"152772","DOI":"10.1016\/j.phymed.2018.11.032","article-title":"Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice","volume":"59","author":"Liang","year":"2019","journal-title":"Phytomedicine"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.050","article-title":"The flavonoid-rich fraction from rhizomes of Smilax glabra Roxb. ameliorates renal oxidative stress and inflammation in uric acid nephropathy rats through promoting uric acid excretion","volume":"111","author":"Wang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.70100","article-title":"Smilax glabra Roxb. meliorates hyperuricemia via regulating renal urate transporter and remodelating intestinal microbiota in mice","volume":"43","author":"Xiao","year":"2025","journal-title":"Cell Biochem Funct"},{"key":"B75","article-title":"The potential of Chinese medicines in the treatment of hyperuricemia","volume":"15","author":"Tang","year":"2023","journal-title":"Am J Transl Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-01056-z","article-title":"Network pharmacology: a crucial approach in traditional Chinese medicine research","volume":"20","author":"Zhai","year":"2025","journal-title":"Chin Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409126","article-title":"Slow metabolism-driven amplification of hepatic PPAR\u03b3 agonism mediates benzbromarone-induced obesity-specific liver injury","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1519054","article-title":"Comprehensive characterisation of the active ingredients of Smilax glabra Roxb based on chemical fingerprinting, metabolic fingerprinting and pharmacodynamic fingerprinting","volume":"16","author":"Shi","year":"2025","journal-title":"Front Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2503703","DOI":"10.1155\/2016\/2503703","article-title":"Effects of Berberine on NLRP3 and IL-1  Expressions in Monocytic THP-1 Cells with Monosodium Urate Crystals-Induced Inflammation","volume":"2016","author":"Liu","year":"2016","journal-title":"Biomed Res Int"},{"key":"B80","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12967-023-04114-6","article-title":"Phospholipase A2 regulates autophagy in gouty arthritis: proteomic and metabolomic studies","volume":"21","author":"Fu","year":"2023","journal-title":"J Transl Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413399","article-title":"Protective effects of dioscin and diosgenin on plateau hyperuricemia by attenuating renal inflammation via EPHX2","volume":"25","author":"Dang","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1863098\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:10:07Z","timestamp":1782893407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1863098\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":81,"alternative-id":["10.3389\/fendo.2026.1863098"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1863098","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1863098"}}